![Senseonics Receives FDA Approval To Expand Eversense CGM Certification To Nurse Practitioners, PAs | Medical Product Outsourcing Senseonics Receives FDA Approval To Expand Eversense CGM Certification To Nurse Practitioners, PAs | Medical Product Outsourcing](https://dev.rodpub.com/images/179/727_350.jpg)
Senseonics Receives FDA Approval To Expand Eversense CGM Certification To Nurse Practitioners, PAs | Medical Product Outsourcing
![FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News](https://www.notebookcheck.net/fileadmin/Notebooks/News/_nc3/Eversense_CGM_system_90_day_now_180_days_blood_glucose_drdNBC.jpg)
FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News
Beyond Type 1 - NOW APPROVED BY THE FDA - a new CGM is on the scene! The Eversense from Senseonics is the first implantable continuous glucose monitor. It lasts 90 days
![In the News... FDA approves Tandem Mobile Bolus, Eversense 180 Day Sensor, and more! - Diabetes Connections In the News... FDA approves Tandem Mobile Bolus, Eversense 180 Day Sensor, and more! - Diabetes Connections](https://diabetes-connections.com/wp-content/uploads/2022/02/In-the-News.png)